img

Global Inactivated Poultry Vaccine Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Inactivated Poultry Vaccine Market Research Report 2024

Inactivated poultry vaccines belong to a class of preventative biologics called "subunit/inactivated virus vaccines." They contain only parts of the virus rather than the entire pathogen. These components are isolated from disease cells and weakened or killed before use in humans and animals so they won't cause illness but still trigger immune responses to protect against subsequent exposure to live viruses.
According to Mr Accuracy reports new survey, global Inactivated Poultry Vaccine market is projected to reach US$ 4173.7 million in 2029, increasing from US$ 3068 million in 2022, with the CAGR of 4.5% during the period of 2024 to 2029.
The global inactivated poultry vaccine market represents one segment within the broader animal vaccines industry that includes subcategories based on species and diseases targeted. This particular subset serves as a critical component in global efforts to manage avian influenza outbreaks caused by deadly H5N8 and H5N6 strains spreading rapidly across continents posing serious threats to human and animal health. To combat this devastating threat, governments around the globe encourage research & development (R&D) investment in effective vaccines adaptable to different regions and birds breeds while companies strive to meet escalating consumer needs driving accelerated evolution towards safer, stronger formulations guaranteeing enhanced protection versus emerging virulent strains. Ongoing studies explore advanced manufacturing techniques and adjuvants promising increased potency and longevity, expanding opportunities for market expansion beyond current offerings leveraged mainly in Asian-Pacific countries where demand remains consistently strong. Suppliers maintain competitive edge via continuous innovation refining production processes ensuring quality performance under diverse conditions extending lifespans maximizing efficiency minimizing waste amidst persistent supply chain complexities faced daily by every participant operating within volatile environments rife with unpredictability testing resilience throughout extended value chains impacting everyone along each step necessitating flexibility adaptability sustaining viability securing future success.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Inactivated Poultry Vaccine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Zoetis
Merck Animal Health
Boehringer Ingelheim
Elanco Animal Health
Phibro Animal Health
Virbac
Hipra
Venkys
Biovet
Ringpu Biology
Ceva Corporate
KM Biologics
Vaxxinova
Japfa Comfeed Indonesia
Nisseiken
Segment by Type
Liquid Vaccines
Freeze-Dried Vaccines

Segment by Application


Avian Encephalomyelitis
Chicken Anaemia
Egg Drop Syndrome
Others

Consumption by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
The Inactivated Poultry Vaccine report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source

Table of Content

1 Inactivated Poultry Vaccine Market Overview
1.1 Product Overview and Scope of Inactivated Poultry Vaccine
1.2 Inactivated Poultry Vaccine Segment by Type
1.2.1 Global Inactivated Poultry Vaccine Market Value Comparison by Type (2024-2034)
1.2.2 Liquid Vaccines
1.2.3 Freeze-Dried Vaccines
1.3 Inactivated Poultry Vaccine Segment by Application
1.3.1 Global Inactivated Poultry Vaccine Market Value by Application: (2024-2034)
1.3.2 Avian Encephalomyelitis
1.3.3 Chicken Anaemia
1.3.4 Egg Drop Syndrome
1.3.5 Others
1.4 Global Inactivated Poultry Vaccine Market Size Estimates and Forecasts
1.4.1 Global Inactivated Poultry Vaccine Revenue 2018-2029
1.4.2 Global Inactivated Poultry Vaccine Sales 2018-2029
1.4.3 Global Inactivated Poultry Vaccine Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Inactivated Poultry Vaccine Market Competition by Manufacturers
2.1 Global Inactivated Poultry Vaccine Sales Market Share by Manufacturers (2018-2024)
2.2 Global Inactivated Poultry Vaccine Revenue Market Share by Manufacturers (2018-2024)
2.3 Global Inactivated Poultry Vaccine Average Price by Manufacturers (2018-2024)
2.4 Global Inactivated Poultry Vaccine Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of Inactivated Poultry Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Inactivated Poultry Vaccine, Product Type & Application
2.7 Inactivated Poultry Vaccine Market Competitive Situation and Trends
2.7.1 Inactivated Poultry Vaccine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Inactivated Poultry Vaccine Players Market Share by Revenue
2.7.3 Global Inactivated Poultry Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Inactivated Poultry Vaccine Retrospective Market Scenario by Region
3.1 Global Inactivated Poultry Vaccine Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Inactivated Poultry Vaccine Global Inactivated Poultry Vaccine Sales by Region: 2018-2029
3.2.1 Global Inactivated Poultry Vaccine Sales by Region: 2018-2024
3.2.2 Global Inactivated Poultry Vaccine Sales by Region: 2024-2029
3.3 Global Inactivated Poultry Vaccine Global Inactivated Poultry Vaccine Revenue by Region: 2018-2029
3.3.1 Global Inactivated Poultry Vaccine Revenue by Region: 2018-2024
3.3.2 Global Inactivated Poultry Vaccine Revenue by Region: 2024-2029
3.4 North America Inactivated Poultry Vaccine Market Facts & Figures by Country
3.4.1 North America Inactivated Poultry Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Inactivated Poultry Vaccine Sales by Country (2018-2029)
3.4.3 North America Inactivated Poultry Vaccine Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Inactivated Poultry Vaccine Market Facts & Figures by Country
3.5.1 Europe Inactivated Poultry Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Inactivated Poultry Vaccine Sales by Country (2018-2029)
3.5.3 Europe Inactivated Poultry Vaccine Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Inactivated Poultry Vaccine Market Facts & Figures by Country
3.6.1 Asia Pacific Inactivated Poultry Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Inactivated Poultry Vaccine Sales by Country (2018-2029)
3.6.3 Asia Pacific Inactivated Poultry Vaccine Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Inactivated Poultry Vaccine Market Facts & Figures by Country
3.7.1 Latin America Inactivated Poultry Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Inactivated Poultry Vaccine Sales by Country (2018-2029)
3.7.3 Latin America Inactivated Poultry Vaccine Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Inactivated Poultry Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Inactivated Poultry Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Inactivated Poultry Vaccine Sales by Country (2018-2029)
3.8.3 Middle East and Africa Inactivated Poultry Vaccine Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Inactivated Poultry Vaccine Sales by Type (2018-2029)
4.1.1 Global Inactivated Poultry Vaccine Sales by Type (2018-2024)
4.1.2 Global Inactivated Poultry Vaccine Sales by Type (2024-2029)
4.1.3 Global Inactivated Poultry Vaccine Sales Market Share by Type (2018-2029)
4.2 Global Inactivated Poultry Vaccine Revenue by Type (2018-2029)
4.2.1 Global Inactivated Poultry Vaccine Revenue by Type (2018-2024)
4.2.2 Global Inactivated Poultry Vaccine Revenue by Type (2024-2029)
4.2.3 Global Inactivated Poultry Vaccine Revenue Market Share by Type (2018-2029)
4.3 Global Inactivated Poultry Vaccine Price by Type (2018-2029)
5 Segment by Application
5.1 Global Inactivated Poultry Vaccine Sales by Application (2018-2029)
5.1.1 Global Inactivated Poultry Vaccine Sales by Application (2018-2024)
5.1.2 Global Inactivated Poultry Vaccine Sales by Application (2024-2029)
5.1.3 Global Inactivated Poultry Vaccine Sales Market Share by Application (2018-2029)
5.2 Global Inactivated Poultry Vaccine Revenue by Application (2018-2029)
5.2.1 Global Inactivated Poultry Vaccine Revenue by Application (2018-2024)
5.2.2 Global Inactivated Poultry Vaccine Revenue by Application (2024-2029)
5.2.3 Global Inactivated Poultry Vaccine Revenue Market Share by Application (2018-2029)
5.3 Global Inactivated Poultry Vaccine Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Zoetis
6.1.1 Zoetis Corporation Information
6.1.2 Zoetis Description and Business Overview
6.1.3 Zoetis Inactivated Poultry Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.1.4 Zoetis Inactivated Poultry Vaccine Product Portfolio
6.1.5 Zoetis Recent Developments/Updates
6.2 Merck Animal Health
6.2.1 Merck Animal Health Corporation Information
6.2.2 Merck Animal Health Description and Business Overview
6.2.3 Merck Animal Health Inactivated Poultry Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.2.4 Merck Animal Health Inactivated Poultry Vaccine Product Portfolio
6.2.5 Merck Animal Health Recent Developments/Updates
6.3 Boehringer Ingelheim
6.3.1 Boehringer Ingelheim Corporation Information
6.3.2 Boehringer Ingelheim Description and Business Overview
6.3.3 Boehringer Ingelheim Inactivated Poultry Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.3.4 Boehringer Ingelheim Inactivated Poultry Vaccine Product Portfolio
6.3.5 Boehringer Ingelheim Recent Developments/Updates
6.4 Elanco Animal Health
6.4.1 Elanco Animal Health Corporation Information
6.4.2 Elanco Animal Health Description and Business Overview
6.4.3 Elanco Animal Health Inactivated Poultry Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Elanco Animal Health Inactivated Poultry Vaccine Product Portfolio
6.4.5 Elanco Animal Health Recent Developments/Updates
6.5 Phibro Animal Health
6.5.1 Phibro Animal Health Corporation Information
6.5.2 Phibro Animal Health Description and Business Overview
6.5.3 Phibro Animal Health Inactivated Poultry Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.5.4 Phibro Animal Health Inactivated Poultry Vaccine Product Portfolio
6.5.5 Phibro Animal Health Recent Developments/Updates
6.6 Virbac
6.6.1 Virbac Corporation Information
6.6.2 Virbac Description and Business Overview
6.6.3 Virbac Inactivated Poultry Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.6.4 Virbac Inactivated Poultry Vaccine Product Portfolio
6.6.5 Virbac Recent Developments/Updates
6.7 Hipra
6.6.1 Hipra Corporation Information
6.6.2 Hipra Description and Business Overview
6.6.3 Hipra Inactivated Poultry Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Hipra Inactivated Poultry Vaccine Product Portfolio
6.7.5 Hipra Recent Developments/Updates
6.8 Venkys
6.8.1 Venkys Corporation Information
6.8.2 Venkys Description and Business Overview
6.8.3 Venkys Inactivated Poultry Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.8.4 Venkys Inactivated Poultry Vaccine Product Portfolio
6.8.5 Venkys Recent Developments/Updates
6.9 Biovet
6.9.1 Biovet Corporation Information
6.9.2 Biovet Description and Business Overview
6.9.3 Biovet Inactivated Poultry Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.9.4 Biovet Inactivated Poultry Vaccine Product Portfolio
6.9.5 Biovet Recent Developments/Updates
6.10 Ringpu Biology
6.10.1 Ringpu Biology Corporation Information
6.10.2 Ringpu Biology Description and Business Overview
6.10.3 Ringpu Biology Inactivated Poultry Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.10.4 Ringpu Biology Inactivated Poultry Vaccine Product Portfolio
6.10.5 Ringpu Biology Recent Developments/Updates
6.11 Ceva Corporate
6.11.1 Ceva Corporate Corporation Information
6.11.2 Ceva Corporate Inactivated Poultry Vaccine Description and Business Overview
6.11.3 Ceva Corporate Inactivated Poultry Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.11.4 Ceva Corporate Inactivated Poultry Vaccine Product Portfolio
6.11.5 Ceva Corporate Recent Developments/Updates
6.12 KM Biologics
6.12.1 KM Biologics Corporation Information
6.12.2 KM Biologics Inactivated Poultry Vaccine Description and Business Overview
6.12.3 KM Biologics Inactivated Poultry Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.12.4 KM Biologics Inactivated Poultry Vaccine Product Portfolio
6.12.5 KM Biologics Recent Developments/Updates
6.13 Vaxxinova
6.13.1 Vaxxinova Corporation Information
6.13.2 Vaxxinova Inactivated Poultry Vaccine Description and Business Overview
6.13.3 Vaxxinova Inactivated Poultry Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.13.4 Vaxxinova Inactivated Poultry Vaccine Product Portfolio
6.13.5 Vaxxinova Recent Developments/Updates
6.14 Japfa Comfeed Indonesia
6.14.1 Japfa Comfeed Indonesia Corporation Information
6.14.2 Japfa Comfeed Indonesia Inactivated Poultry Vaccine Description and Business Overview
6.14.3 Japfa Comfeed Indonesia Inactivated Poultry Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.14.4 Japfa Comfeed Indonesia Inactivated Poultry Vaccine Product Portfolio
6.14.5 Japfa Comfeed Indonesia Recent Developments/Updates
6.15 Nisseiken
6.15.1 Nisseiken Corporation Information
6.15.2 Nisseiken Inactivated Poultry Vaccine Description and Business Overview
6.15.3 Nisseiken Inactivated Poultry Vaccine Sales, Revenue and Gross Margin (2018-2024)
6.15.4 Nisseiken Inactivated Poultry Vaccine Product Portfolio
6.15.5 Nisseiken Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Inactivated Poultry Vaccine Industry Chain Analysis
7.2 Inactivated Poultry Vaccine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Inactivated Poultry Vaccine Production Mode & Process
7.4 Inactivated Poultry Vaccine Sales and Marketing
7.4.1 Inactivated Poultry Vaccine Sales Channels
7.4.2 Inactivated Poultry Vaccine Distributors
7.5 Inactivated Poultry Vaccine Customers
8 Inactivated Poultry Vaccine Market Dynamics
8.1 Inactivated Poultry Vaccine Industry Trends
8.2 Inactivated Poultry Vaccine Market Drivers
8.3 Inactivated Poultry Vaccine Market Challenges
8.4 Inactivated Poultry Vaccine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Inactivated Poultry Vaccine Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Inactivated Poultry Vaccine Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Inactivated Poultry Vaccine Market Competitive Situation by Manufacturers in 2022
Table 4. Global Inactivated Poultry Vaccine Sales (K Units) of Key Manufacturers (2018-2024)
Table 5. Global Inactivated Poultry Vaccine Sales Market Share by Manufacturers (2018-2024)
Table 6. Global Inactivated Poultry Vaccine Revenue (US$ Million) by Manufacturers (2018-2024)
Table 7. Global Inactivated Poultry Vaccine Revenue Share by Manufacturers (2018-2024)
Table 8. Global Market Inactivated Poultry Vaccine Average Price (US$/Unit) of Key Manufacturers (2018-2024)
Table 9. Global Key Players of Inactivated Poultry Vaccine, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of Inactivated Poultry Vaccine, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Inactivated Poultry Vaccine, Product Type & Application
Table 12. Global Key Manufacturers of Inactivated Poultry Vaccine, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Inactivated Poultry Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Inactivated Poultry Vaccine as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Inactivated Poultry Vaccine Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Inactivated Poultry Vaccine Sales by Region (2018-2024) & (K Units)
Table 18. Global Inactivated Poultry Vaccine Sales Market Share by Region (2018-2024)
Table 19. Global Inactivated Poultry Vaccine Sales by Region (2024-2029) & (K Units)
Table 20. Global Inactivated Poultry Vaccine Sales Market Share by Region (2024-2029)
Table 21. Global Inactivated Poultry Vaccine Revenue by Region (2018-2024) & (US$ Million)
Table 22. Global Inactivated Poultry Vaccine Revenue Market Share by Region (2018-2024)
Table 23. Global Inactivated Poultry Vaccine Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Inactivated Poultry Vaccine Revenue Market Share by Region (2024-2029)
Table 25. North America Inactivated Poultry Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Inactivated Poultry Vaccine Sales by Country (2018-2024) & (K Units)
Table 27. North America Inactivated Poultry Vaccine Sales by Country (2024-2029) & (K Units)
Table 28. North America Inactivated Poultry Vaccine Revenue by Country (2018-2024) & (US$ Million)
Table 29. North America Inactivated Poultry Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Inactivated Poultry Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Inactivated Poultry Vaccine Sales by Country (2018-2024) & (K Units)
Table 32. Europe Inactivated Poultry Vaccine Sales by Country (2024-2029) & (K Units)
Table 33. Europe Inactivated Poultry Vaccine Revenue by Country (2018-2024) & (US$ Million)
Table 34. Europe Inactivated Poultry Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Inactivated Poultry Vaccine Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Inactivated Poultry Vaccine Sales by Region (2018-2024) & (K Units)
Table 37. Asia Pacific Inactivated Poultry Vaccine Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Inactivated Poultry Vaccine Revenue by Region (2018-2024) & (US$ Million)
Table 39. Asia Pacific Inactivated Poultry Vaccine Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Inactivated Poultry Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Inactivated Poultry Vaccine Sales by Country (2018-2024) & (K Units)
Table 42. Latin America Inactivated Poultry Vaccine Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Inactivated Poultry Vaccine Revenue by Country (2018-2024) & (US$ Million)
Table 44. Latin America Inactivated Poultry Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Inactivated Poultry Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Inactivated Poultry Vaccine Sales by Country (2018-2024) & (K Units)
Table 47. Middle East & Africa Inactivated Poultry Vaccine Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Inactivated Poultry Vaccine Revenue by Country (2018-2024) & (US$ Million)
Table 49. Middle East & Africa Inactivated Poultry Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Inactivated Poultry Vaccine Sales (K Units) by Type (2018-2024)
Table 51. Global Inactivated Poultry Vaccine Sales (K Units) by Type (2024-2029)
Table 52. Global Inactivated Poultry Vaccine Sales Market Share by Type (2018-2024)
Table 53. Global Inactivated Poultry Vaccine Sales Market Share by Type (2024-2029)
Table 54. Global Inactivated Poultry Vaccine Revenue (US$ Million) by Type (2018-2024)
Table 55. Global Inactivated Poultry Vaccine Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Inactivated Poultry Vaccine Revenue Market Share by Type (2018-2024)
Table 57. Global Inactivated Poultry Vaccine Revenue Market Share by Type (2024-2029)
Table 58. Global Inactivated Poultry Vaccine Price (US$/Unit) by Type (2018-2024)
Table 59. Global Inactivated Poultry Vaccine Price (US$/Unit) by Type (2024-2029)
Table 60. Global Inactivated Poultry Vaccine Sales (K Units) by Application (2018-2024)
Table 61. Global Inactivated Poultry Vaccine Sales (K Units) by Application (2024-2029)
Table 62. Global Inactivated Poultry Vaccine Sales Market Share by Application (2018-2024)
Table 63. Global Inactivated Poultry Vaccine Sales Market Share by Application (2024-2029)
Table 64. Global Inactivated Poultry Vaccine Revenue (US$ Million) by Application (2018-2024)
Table 65. Global Inactivated Poultry Vaccine Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Inactivated Poultry Vaccine Revenue Market Share by Application (2018-2024)
Table 67. Global Inactivated Poultry Vaccine Revenue Market Share by Application (2024-2029)
Table 68. Global Inactivated Poultry Vaccine Price (US$/Unit) by Application (2018-2024)
Table 69. Global Inactivated Poultry Vaccine Price (US$/Unit) by Application (2024-2029)
Table 70. Zoetis Corporation Information
Table 71. Zoetis Description and Business Overview
Table 72. Zoetis Inactivated Poultry Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 73. Zoetis Inactivated Poultry Vaccine Product
Table 74. Zoetis Recent Developments/Updates
Table 75. Merck Animal Health Corporation Information
Table 76. Merck Animal Health Description and Business Overview
Table 77. Merck Animal Health Inactivated Poultry Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 78. Merck Animal Health Inactivated Poultry Vaccine Product
Table 79. Merck Animal Health Recent Developments/Updates
Table 80. Boehringer Ingelheim Corporation Information
Table 81. Boehringer Ingelheim Description and Business Overview
Table 82. Boehringer Ingelheim Inactivated Poultry Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 83. Boehringer Ingelheim Inactivated Poultry Vaccine Product
Table 84. Boehringer Ingelheim Recent Developments/Updates
Table 85. Elanco Animal Health Corporation Information
Table 86. Elanco Animal Health Description and Business Overview
Table 87. Elanco Animal Health Inactivated Poultry Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 88. Elanco Animal Health Inactivated Poultry Vaccine Product
Table 89. Elanco Animal Health Recent Developments/Updates
Table 90. Phibro Animal Health Corporation Information
Table 91. Phibro Animal Health Description and Business Overview
Table 92. Phibro Animal Health Inactivated Poultry Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 93. Phibro Animal Health Inactivated Poultry Vaccine Product
Table 94. Phibro Animal Health Recent Developments/Updates
Table 95. Virbac Corporation Information
Table 96. Virbac Description and Business Overview
Table 97. Virbac Inactivated Poultry Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 98. Virbac Inactivated Poultry Vaccine Product
Table 99. Virbac Recent Developments/Updates
Table 100. Hipra Corporation Information
Table 101. Hipra Description and Business Overview
Table 102. Hipra Inactivated Poultry Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 103. Hipra Inactivated Poultry Vaccine Product
Table 104. Hipra Recent Developments/Updates
Table 105. Venkys Corporation Information
Table 106. Venkys Description and Business Overview
Table 107. Venkys Inactivated Poultry Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 108. Venkys Inactivated Poultry Vaccine Product
Table 109. Venkys Recent Developments/Updates
Table 110. Biovet Corporation Information
Table 111. Biovet Description and Business Overview
Table 112. Biovet Inactivated Poultry Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 113. Biovet Inactivated Poultry Vaccine Product
Table 114. Biovet Recent Developments/Updates
Table 115. Ringpu Biology Corporation Information
Table 116. Ringpu Biology Description and Business Overview
Table 117. Ringpu Biology Inactivated Poultry Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 118. Ringpu Biology Inactivated Poultry Vaccine Product
Table 119. Ringpu Biology Recent Developments/Updates
Table 120. Ceva Corporate Corporation Information
Table 121. Ceva Corporate Description and Business Overview
Table 122. Ceva Corporate Inactivated Poultry Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 123. Ceva Corporate Inactivated Poultry Vaccine Product
Table 124. Ceva Corporate Recent Developments/Updates
Table 125. KM Biologics Corporation Information
Table 126. KM Biologics Description and Business Overview
Table 127. KM Biologics Inactivated Poultry Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 128. KM Biologics Inactivated Poultry Vaccine Product
Table 129. KM Biologics Recent Developments/Updates
Table 130. Vaxxinova Corporation Information
Table 131. Vaxxinova Description and Business Overview
Table 132. Vaxxinova Inactivated Poultry Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 133. Vaxxinova Inactivated Poultry Vaccine Product
Table 134. Vaxxinova Recent Developments/Updates
Table 135. Japfa Comfeed Indonesia Corporation Information
Table 136. Japfa Comfeed Indonesia Description and Business Overview
Table 137. Japfa Comfeed Indonesia Inactivated Poultry Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 138. Japfa Comfeed Indonesia Inactivated Poultry Vaccine Product
Table 139. Japfa Comfeed Indonesia Recent Developments/Updates
Table 140. Nisseiken Corporation Information
Table 141. Nisseiken Description and Business Overview
Table 142. Nisseiken Inactivated Poultry Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 143. Nisseiken Inactivated Poultry Vaccine Product
Table 144. Nisseiken Recent Developments/Updates
Table 145. Key Raw Materials Lists
Table 146. Raw Materials Key Suppliers Lists
Table 147. Inactivated Poultry Vaccine Distributors List
Table 148. Inactivated Poultry Vaccine Customers List
Table 149. Inactivated Poultry Vaccine Market Trends
Table 150. Inactivated Poultry Vaccine Market Drivers
Table 151. Inactivated Poultry Vaccine Market Challenges
Table 152. Inactivated Poultry Vaccine Market Restraints
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Inactivated Poultry Vaccine
Figure 2. Global Inactivated Poultry Vaccine Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Inactivated Poultry Vaccine Market Share by Type in 2022 & 2029
Figure 4. Liquid Vaccines Product Picture
Figure 5. Freeze-Dried Vaccines Product Picture
Figure 6. Global Inactivated Poultry Vaccine Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 7. Global Inactivated Poultry Vaccine Market Share by Application in 2022 & 2029
Figure 8. Avian Encephalomyelitis
Figure 9. Chicken Anaemia
Figure 10. Egg Drop Syndrome
Figure 11. Others
Figure 12. Global Inactivated Poultry Vaccine Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Inactivated Poultry Vaccine Market Size (2018-2029) & (US$ Million)
Figure 14. Global Inactivated Poultry Vaccine Sales (2018-2029) & (K Units)
Figure 15. Global Inactivated Poultry Vaccine Average Price (US$/Unit) & (2018-2029)
Figure 16. Inactivated Poultry Vaccine Report Years Considered
Figure 17. Inactivated Poultry Vaccine Sales Share by Manufacturers in 2022
Figure 18. Global Inactivated Poultry Vaccine Revenue Share by Manufacturers in 2022
Figure 19. The Global 5 and 10 Largest Inactivated Poultry Vaccine Players: Market Share by Revenue in 2022
Figure 20. Inactivated Poultry Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 21. Global Inactivated Poultry Vaccine Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 22. North America Inactivated Poultry Vaccine Sales Market Share by Country (2018-2029)
Figure 23. North America Inactivated Poultry Vaccine Revenue Market Share by Country (2018-2029)
Figure 24. U.S. Inactivated Poultry Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 25. Canada Inactivated Poultry Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 26. Europe Inactivated Poultry Vaccine Sales Market Share by Country (2018-2029)
Figure 27. Europe Inactivated Poultry Vaccine Revenue Market Share by Country (2018-2029)
Figure 28. Germany Inactivated Poultry Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. France Inactivated Poultry Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. U.K. Inactivated Poultry Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Italy Inactivated Poultry Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Russia Inactivated Poultry Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. Asia Pacific Inactivated Poultry Vaccine Sales Market Share by Region (2018-2029)
Figure 34. Asia Pacific Inactivated Poultry Vaccine Revenue Market Share by Region (2018-2029)
Figure 35. China Inactivated Poultry Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. Japan Inactivated Poultry Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. South Korea Inactivated Poultry Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. India Inactivated Poultry Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Australia Inactivated Poultry Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Taiwan Inactivated Poultry Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Indonesia Inactivated Poultry Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Thailand Inactivated Poultry Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Malaysia Inactivated Poultry Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Philippines Inactivated Poultry Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Latin America Inactivated Poultry Vaccine Sales Market Share by Country (2018-2029)
Figure 46. Latin America Inactivated Poultry Vaccine Revenue Market Share by Country (2018-2029)
Figure 47. Mexico Inactivated Poultry Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Brazil Inactivated Poultry Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. Argentina Inactivated Poultry Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. Middle East & Africa Inactivated Poultry Vaccine Sales Market Share by Country (2018-2029)
Figure 51. Middle East & Africa Inactivated Poultry Vaccine Revenue Market Share by Country (2018-2029)
Figure 52. Turkey Inactivated Poultry Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. Saudi Arabia Inactivated Poultry Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 54. U.A.E Inactivated Poultry Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 55. Global Sales Market Share of Inactivated Poultry Vaccine by Type (2018-2029)
Figure 56. Global Revenue Market Share of Inactivated Poultry Vaccine by Type (2018-2029)
Figure 57. Global Inactivated Poultry Vaccine Price (US$/Unit) by Type (2018-2029)
Figure 58. Global Sales Market Share of Inactivated Poultry Vaccine by Application (2018-2029)
Figure 59. Global Revenue Market Share of Inactivated Poultry Vaccine by Application (2018-2029)
Figure 60. Global Inactivated Poultry Vaccine Price (US$/Unit) by Application (2018-2029)
Figure 61. Inactivated Poultry Vaccine Value Chain
Figure 62. Inactivated Poultry Vaccine Production Process
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Distributors Profiles
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed